Ropes & Gray represented Cullinan Oncology in the deal. Cullinan Oncology announced a strategic collaboration with Taiho Pharmaceutical under which Taiho will acquire Cullinan Oncology’s subsidiary Cullinan […]
Cullinan Oncology’s Collaboration with Taiho Pharmaceutical
Cornell Capital’s Acquisition of Advancing Eyecare
Weil, Gotshal & Manges represented Cornell Capital, Kramer Levin represented Atlantic Street Capital in the transaction. Atlantic Street Capital has entered into an agreement to sell […]
TSG’s Acquisition of Cadogan Tate
Ropes & Gray has advised TSG Consumer Partners on the deal. TSG Consumer Partners, a leading private equity firm, announced its entry into an agreement by which […]
Pfizer’s Acquisition of Biohaven Pharmaceutical
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C and Maples and […]
Huadong Medicine’s Collaboration with Kiniksa Pharmaceuticals
Greenberg Traurig represented Huadong Medicine on the deal, while Ropes & Gray advised Kiniksa Pharmaceuticals. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly owned subsidiary of […]
Zip Co Limited’s A$491 Million Takeover of Sezzle
BofA Securities and Jarden-Evercore acted as financial advisers to Zip. Skadden, Arps, Slate, Meagher & Flom LLP acted as U.S. legal counsel and Arnold Bloch Leibler […]
Ovid Therapeutics’ Partnership With Healx
Ropes & Gray advised Ovid Therapeutics on the deal. Ovid Therapeutics announced a strategic partnership with U.K.-based Healx, an AI-powered technology company, that granted Healx the […]
Forescout Technologies’ Acquisition of CyberMDX
Ropes & Gray represented Forescout Technologies in the transaction. Forescout Technologies, Inc. (a portfolio company of Advent International and Crosspoint Capital Partners) executed its acquisition of […]
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors […]
Pfizer’s Collaboration With Biohaven Pharmaceutical Company
Ropes & Gray represented Pfizer in the deal. Pfizer announced its collaboration arrangement with Biohaven Pharmaceutical Company to commercialize rimegepant, a therapy approved in the U.S. as […]
Ironwood Pharmaceuticals’ Rare Autoimmune Disease Collaboration with COUR Pharmaceuticals
Ropes & Gray represented Ironwood Pharmaceuticals in the collaboration and license option agreement with COUR Pharmaceutical Development Company. The agreement gives Ironwood an option to acquire […]
Warburg Pincus’ US$200 Million Strategic Investment in Fortegra
Sidley Austin and Ropes & Gray advised Tiptree Inc. and Fortegra on the insurance and regulatory aspects of the deal. Warburg Pincus, a leading global growth […]